Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 8, 2020
- Accepted in final form April 17, 2020
- First Published May 28, 2020.
Author Disclosures
- Markus Reindl, PhD
- Markus Reindl, PhD
NONE
NONE
NONE
PLOS ONE, academic editor, 2012,
NONE
NONE
NONE
NONE
NONE
The University Hospital and Medical University of Innsbruck (Austria, Markus Reindl) receive payments for antibody assays (NMDAR, AQP4 and other autoantibodies) and for MOG and AQP4 antibody validation experiments organized by Euroimmun (Luebeck, Germany).
NONE
Euroimmun AG, Germany
(1) Austrian Science Funds (FWF), project P32699, PI, 2019-2022 (2) Austrian Federal Ministry of Science, Research and Education, grant BIG WIG MS, PI, 2013-2017 (3) Austrian Research promotion Agency (FFG), Bridge 1 project Nr. 853209, PI, 2016-2018 (4) Austrian Science Funds (FWF), project W1206, PI, 2007-2018 (5), Austrian Science Funds (FWF), project ZFP326990, PI, 2019-2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence
Dr. Reindl markus.reindl{at}i-med.ac.at
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto et al.Neurology, January 10, 2014 -
Article
Fulminant demyelinating encephalomyelitisInsights from antibody studies and neuropathologyFranziska Di Pauli, Romana Höftberger, Markus Reindl et al.Neurology - Neuroimmunology Neuroinflammation, November 04, 2015 -
Article
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSDJiraporn Jitprapaikulsan, James P. Fryer, Masoud Majed et al.Neurology: Neuroimmunology & Neuroinflammation, May 28, 2020 -
Article
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritisSudarshini Ramanathan, Stephen W. Reddel, Andrew Henderson et al.Neurology - Neuroimmunology Neuroinflammation, October 29, 2014